Rockefeller Financial Services’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-3,053
Closed -$154K 623
2015
Q4
$154K Buy
+3,053
New +$156K ﹤0.01% 356
2015
Q2
Sell
-3,872
Closed -$223K 483
2015
Q1
$223K Hold
3,872
﹤0.01% 317
2014
Q4
$207K Sell
3,872
-131,146
-97% -$7.34M ﹤0.01% 300
2014
Q3
$7.76M Sell
135,018
-63,086
-32% -$3.87M 0.17% 99
2014
Q2
$13.2M Sell
198,104
-374
-0.2% -$25.3K 0.3% 76
2014
Q1
$13.3M Buy
198,478
+4,242
+2% +$287K 0.29% 89
2013
Q4
$13M Buy
194,236
+40,402
+26% +$2.62M 0.28% 93
2013
Q3
$9.65M Buy
153,834
+3,532
+2% +$227K 0.22% 101
2013
Q2
$9.39M Buy
+150,302
New +$9.54M 0.23% 92

Other funds holding GSK

Rockefeller Financial Services's GSK Position: Q1 2016 in Review

Rockefeller Financial Services sold out of GSK (GSK) in Q1 2016, closing a stake of 3,053 shares — an estimated $154K sold.

Rockefeller Financial Services first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $13.3M in Q1 2014. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

  • Rockefeller Financial Services reported no remaining GSK position as of Q1 2016 after selling out during the quarter.
  • Rockefeller Financial Services sold 3,053 GSK shares in Q1 2016, an estimated $154K.
  • Rockefeller Financial Services first reported a position in GSK in Q2 2013 and held it in 9 quarters.
  • Rockefeller Financial Services's GSK position peaked at $13.3M in Q1 2014.
  • 726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Rockefeller Financial Services's 13F filing for Q1 2016, filed 28 Apr 2016.